Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Neurohr

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Therapeutic Drug Monitoring|March 11, 2017
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityDaniela Stelzer, Alexandra Weber, Franziska Ihle, et al.
Frontiers in Medicine|June 20, 2022
Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans SyndromeNikolaus Kneidinger, Alessandro Ghiani, Katrin Milger, et al.
Investigative Radiology|January 5, 2013
Assessing pulmonary perfusion in emphysema: automated quantification of perfused blood volume in dual-energy CTPAFelix G Meinel, Anita Graef, Sven F Thieme, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2011
Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: a prospective, randomized studyFranziska Ihle, Claus Neurohr, Patrick Huppmann, et al.
Lung|May 16, 2018
Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and ManagementGabriela Leuschner, Fredrik Reiter, Florian Stocker, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider]Ekkehard Grünig, Michael Halank, Claus Neurohr, et al.
Respiratory Research|May 24, 2011
Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Claus Neurohr, Anna L Hoffmann, Patrick Huppmann, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 21, 2019
Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung diseaseSanziana R I Schiopu, Mathias Zacherl, Andrei Todica, et al.
Respiratory Medicine|December 5, 2018
Asthma features in severe COPD: Identifying treatable traitsSandhya Matthes, Jakob Stadler, Jürgen Barton, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Pulmonary hypertension associated with lung disease]Michael Halank, Katarina E Zeder, Natascha Sommer, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Therapeutic Drug Monitoring|March 11, 2017
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityDaniela Stelzer, Alexandra Weber, Franziska Ihle, et al.
Frontiers in Medicine|June 20, 2022
Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans SyndromeNikolaus Kneidinger, Alessandro Ghiani, Katrin Milger, et al.
Investigative Radiology|January 5, 2013
Assessing pulmonary perfusion in emphysema: automated quantification of perfused blood volume in dual-energy CTPAFelix G Meinel, Anita Graef, Sven F Thieme, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2011
Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: a prospective, randomized studyFranziska Ihle, Claus Neurohr, Patrick Huppmann, et al.
Lung|May 16, 2018
Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and ManagementGabriela Leuschner, Fredrik Reiter, Florian Stocker, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider]Ekkehard Grünig, Michael Halank, Claus Neurohr, et al.
Respiratory Research|May 24, 2011
Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Claus Neurohr, Anna L Hoffmann, Patrick Huppmann, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 21, 2019
Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung diseaseSanziana R I Schiopu, Mathias Zacherl, Andrei Todica, et al.
Respiratory Medicine|December 5, 2018
Asthma features in severe COPD: Identifying treatable traitsSandhya Matthes, Jakob Stadler, Jürgen Barton, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2023
[Pulmonary hypertension associated with lung disease]Michael Halank, Katarina E Zeder, Natascha Sommer, et al.
Pageof 12